n = 77 | |
---|---|
Age (years) | 64 [53; 70] |
Female gender | 19 (25%) |
Comorbidities | |
Chronic kidney disease | 5 (7%) |
Hypertension | 26 (34%) |
Diabetes | 14 (18%) |
Cancer | 26 (34%) |
Cirrhosis | 3 (4%) |
Congestive heart failure | 4 (5%) |
Chronic obstructive pulmonary disease | 1 (1%) |
Main ICU admission diagnosis | |
Acute respiratory failure | 26 (34%) |
Coma | 19 (25%) |
Sepsis or septic shock | 12 (16%) |
Other shock | 8 (10%) |
Exacerbation of chronic respiratory failure | 3 (4%) |
Cardiac arrest | 2 (3%) |
Multiple organ failure | 2 (3%) |
Other | 5 (6%) |
SAPSa II at admission | 46 [35; 56] |
Serum creatinine concentration at inclusion (μmol/L) | 69 [48; 109] |
Computed tomography explored areab | |
Brain | 29 (38%) |
Thorax | 40 (52%) |
Abdomen | 29 (38%) |
Pelvis | 26 (34%) |
Soft tissue/limbs | 1 (1%) |
Spine | 1 (1%) |
Iodinated contrast medium infused | |
Iohexol 300 mg/mL iodine | 3 (4%) |
Iohexol 350 mg/mL iodine | 26 (34%) |
Iobitridol 350 mg/mL iodine | 26 (34%) |
Iopromide 370 mg/mL iodine | 17 (22%) |
Iomeprol 350 mg/mL iodine | 1 (1%) |
Iomeprol 400 mg/mL iodine | 4 (5%) |
Volume of iodinated contrast medium infused (mL) | 96 [60; 120] |